WFM
OSIR

Wilmington Funds Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Wilmington Funds Management’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10,757
Closed -$141K – 870
2014
Q1 		$141K Sell
10,757
-3,303
-23% -$51.7K 0.02% 715
2013
Q4 		$226K Sell
14,060
-1,874
-12% -$29.9K 0.02% 669
2013
Q3 		$265K Buy
+15,934
New +$236K 0.03% 598

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Wilmington Funds Management's OSIR Position: Q2 2014 in Review

Wilmington Funds Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2014, closing a stake of 10,757 shares — an estimated $141K sold.

Wilmington Funds Management first reported a position in OSIR in Q3 2013 and held it in 3 quarters. The position peaked at $265K in Q3 2013. 67 funds tracked by Wall St. Rank hold OSIR as of Q2 2014.

  • Wilmington Funds Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
  • Wilmington Funds Management sold 10,757 Osiris Therapeutics, Inc. Common Stock shares in Q2 2014, an estimated $141K.
  • Wilmington Funds Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2013 and held it in 3 quarters.
  • Wilmington Funds Management's Osiris Therapeutics, Inc. Common Stock position peaked at $265K in Q3 2013.
  • 67 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.